β2-agonists can break hearts in asthmatics with LQTS

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1666, 2008-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Long and Short of β₂-agonists

By Lötvall J.

Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 6, 2002-12 ,pp. : 497-501

Academic Press

Access to resources Recommend Favorite

Long-acting β₂ agonists

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite

New long acting β₂ agonists

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 273-277

Informa Healthcare

Access to resources Recommend Favorite

New long-acting β₂-agonists

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 9, 2004-09 ,pp. : 1385-1388

Informa Healthcare

Access to resources Recommend Favorite

Pfizer's dual-acting β₂ agonists/muscarinic M₃ antagonists

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 9, 2008-09 ,pp. : 1091-1096

Informa Healthcare

Access to resources Recommend Favorite